Loading...
Price History
Market Data
| Market Cap | - |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | -4.46 |
| Dividend Yield | - |
| D/E Ratio | 1.17 |
| Current Ratio | 1.36 |
| Currency | USD |
Key Financial Metrics
1.39B
Revenue
-242.47M
Net Income
-4.46
EPS (Diluted)
247.41M
Free Cash Flow
Profitability
Gross Margin
68.0%
Operating Margin
14.4%
Net Profit Margin
-17.5%
EBITDA
199.39M
Returns & Efficiency
Return on Assets (ROA)
-9.3%
Return on Equity (ROE)
-20.2%
Dividend Yield
-
EPS
-4.46
Financial Health
Total Assets
2.61B
Total Debt
407.57M
Debt to Equity
1.17x
Current Ratio
1.36
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| HQ | LONDON |
| Fiscal Year | 2025 |
Peers
129.39B
P/E: --
MEDTRONIC PLC
MDT
129.39B
P/E: --
MASIMO CORP
MASI
7.60B
P/E: --
3.02B
P/E: 35.5
CONMED CORP
CNMD
1.29B
P/E: 20.3
232.34M
P/E: --
--
P/E: --
ST JUDE MEDICAL INC
None
--
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap-
P/E Ratio (TTM)-
Price to Book-
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin68.0%
Operating Margin14.4%
Net Margin-17.5%
ROE-20.2%
ROA-9.3%
Leverage & Liquidity
Debt to Equity1.17
Current Ratio1.36
Total Debt$407.57M
Total Assets$2.61B
Stockholders' Equity$1.20B
Income Statement (FY 2025)
Revenue$1.39B
Gross Profit$944.39M
Operating Income$199.39M
Net Income$-242.47M
EPS (Diluted)$-4.46
Cash Flow (FY 2025)
Free Cash Flow$247.41M
Cash & Equivalents$635.55M
Revenue Growth10.7%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 20 EASTBOURNE TERRACE LONDON, None W2 6LG |
| Phone | 4402033250662 |
| Incorporated | None, GB |
| EIN | 981268150 |
| Fiscal Year End | 1231 |
| Stockholders' Equity | $1.20B |
| Cash & Equivalents | $635.55M |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-25
Local
IRANNOTICE
IRANNOTICE Filing
SEC regulatory filing
Filed: 2026-02-25
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-25
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-02-12
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-02-09
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-05
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-06
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-05-07
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-04-30
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-02-25
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-10-31
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-08-01
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-05-03
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2024-04-26
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2024-02-29
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | LIVANOVA PLC |
| Ticker | LIVN |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | -- |
| Headquarters | LONDON |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | - |
| Revenue | 1.39B |
| Net Income | -242.47M |
| P/E Ratio | - |
| EPS | -4.46 |
| Net Margin | -17.5% |
| ROE | -20.2% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...